Radiation therapy of testicular non-seminomas

Journal Article · Mon Feb 01 00:00:00 EST 1982 · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

DOI:https://doi.org/10.1016/0360-3016(82)90510-7· OSTI ID:6580977

Van der Werf-Messing, B; Hop, W C.J.

The prognosis of 121 patients with a non-seminoma testicular tumor MTI or MTU was assessed. The clinical lymph node involvement and the T-category of the primary had a significant bearing on prognosis, which is completely determined by pulmonary relapse. The low-risk group (9% pulmonary relapse, all curable) is characterized by a primary category T/sub 1/ or T/sub 2/ with negative lymphangiography. The percentage of favorable patients is significantly higher if there is malignant teratoma intermediate (MTI) rather than malignant teratoma undifferentiated (MTU) histology. Systematic use of tumor markers (..beta../sub 1/-HCG and alpha fetoprotein), and perhaps an assessment of vascular invasion in the primary, might be useful to identify those patients in the unfavorable group who might benefit from elective chemotherapy.

• OSTI ID: 6580977
• Journal Information: Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 8:2
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
LYMPH NODES
EXTERNAL IRRADIATION
FRACTIONATED IRRADIATION
NEOPLASMS
RADIOTHERAPY
EVALUATION
TESTES
LUNGS
METASTASES
PATIENTS
REVIEWS
BODY
DISEASES
DOCUMENT TYPES
GONADS
IRRADIATION
LYMPHATIC SYSTEM
MALE GENITALS
MEDICINE
NUCLEAR MEDICINE
ORGANS
RADIOLOGY
RESPIRATORY SYSTEM
THERAPY
550603* - Medicine- External Radiation in Therapy- (1980-)